Histone demethylase inhibitors
US8987461B2 · kind B2 · utility
12Cited by
40References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2013 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Dec 15, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.